Mr Denis Hanley AM
MBA FAICD FCPA
Non-Executive Chairman
Mr Denis Hanley is recognised as a leading expert in developing and commercialising new Australian technology. He also has extensive experience in growing Australian corporations to become successful global entities. He is a Fellow of the Australian Institute of Company Directors and a Fellow of CPA Australia.
In 1994, Denis was awarded membership in the Order of Australia and the Clunies Ross Medal for his work in helping Australian technology businesses commercialise their assets. He is a foundation member of the Principals group of companies, which help Australian technology businesses commercialise their technologies.
Denis is the Chairman of Pharmaxis Ltd another Australian technology company which is successfully bringing important medical technologies to the global market.
Also, for 14 years Denis led Memtec Ltd, first as Managing Director and later as Chairman and CEO. During this time Memtec grew from a small start-up company with four employees, to become a successful NASDAQ and later NYSE-listed global business with 1800 employees, multiple technology platforms and a market capitalisation of approximately A$500 million.
Prior to his Memtec experience, Denis spent more than a decade at the international medical company Baxter Laboratories, both in the U.S. and also as their Australian Managing Director.
Denis has also served as a Board member and then Chairman of the IR&D Board, a Member of the Australian Prime Minister‚ Science and Engineering Council, a Member of the Industry & Higher Education round table, a Member of the Australian Council for the Development of Environmental Opportunity, a member of the Co-operative Research Centers Oversight Committee and as Chairman of Judges at the Australian Technology Awards. In 1976 Denis was awarded an MBA with High Distinction and was named a Baker Scholar at the Harvard Graduate School of Business Administration.